Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naive chronic hepatitis B patients with concurrent hepatic steatosis.
Li J, Xu L, Rui F, Tran S, Tsai PC, Tan Y, Toyoda H, Zeng QL, Trinh H, Hsu YC, Watanabe T, Abe H, Motoyama H, Yoshimaru Y, Suzuki T, Arai T, Atsukawa M, Vutien P, Marciano S, Bai X, Ni W, Geng N, Tseng CH, Liu J, Mi Y, Liu J, Ye Y, Zhu L, Chen RY, Zhu C, Maeda M, Liu JK, Henry L, Yeh ML, Huang CF, Huang JF, Dai CY, Gadano A, Cheung R, Chuang WL, Enomoto M, Tanaka Y, Aishima S, Yu ML, Wu C, Shi J, Nguyen MH.
Hepatology. 2026 May 1;83(5):1273-1286. doi: 10.1097/HEP.0000000000001442. Epub 2025 Jun 25.
Treatment of chronic viral hepatitis.
Marcellin P, Benhamou JP.
Baillieres Clin Gastroenterol. 1994 Jun;8(2):233-53. doi: 10.1016/0950-3528(94)90003-5.
Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?
Kaymakoglu S, Cakaloglu Y, Demir K, Türkoglu S, Badur S, Gürel S, Beşişik F, Cevikbaş U, Okten A.
J Hepatol. 1998 Jan;28(1):78-83. doi: 10.1016/s0168-8278(98)80205-5.
Essential hypertension and chronic viral hepatitis.
Parrilli G, Manguso F, Orsini L, Coccoli P, Vecchione R, Terracciano L, De Luca N, Cirillo N, Abazia C, Budillon G, Marchesini G.
Dig Liver Dis. 2007 May;39(5):466-72. doi: 10.1016/j.dld.2007.01.009. Epub 2007 Mar 21.
Differential HCC risk among HBV indeterminate types at baseline and by phase transition.
Huang R, Trinh HN, Yasuda S, Chau A, Maeda M, Do AT, Huang DQ, Ito T, Honda T, Ishigami M, Kozuka R, Preda CM, Tseng CH, Marciano S, Tsai PC, Lee DH, Wong CC, Do S, Kawashima K, Zhang J, Marin RI, Sandra I, Li J, Ogawa E, Cheung R, Li J, Yu ML, Gadano A, Hsu YC, Buti M, Enomoto M, Lim SG, Wu C, Toyoda H, Nguyen MH.
Gut. 2025 Oct 8;74(11):1873-1882. doi: 10.1136/gutjnl-2025-335033.
Type B hepatitis: progression to chronic hepatitis.
Wright R.
Clin Gastroenterol. 1980 Jan;9(1):97-115.
Severe viral hepatitis type B in infancy;
Dupuy JM, Frommel D, Alagille D.
Lancet. 1975 Jan 25;1(7900):191-4. doi: 10.1016/s0140-6736(75)91359-8.
Viral hepatitis: a review.
Acorn CJ, Millar CC, Hoffman SK, Lyle WM.
Optom Vis Sci. 1995 Oct;72(10):763-9. doi: 10.1097/00006324-199510000-00010.
Type I interferon receptor signaling delays Kupffer cell replenishment during acute fulminant viral hepatitis.
Borst K, Frenz T, Spanier J, Tegtmeyer PK, Chhatbar C, Skerra J, Ghita L, Namineni S, Lienenklaus S, Köster M, Heikenwaelder M, Sutter G, Kalinke U.
J Hepatol. 2018 Apr;68(4):682-690. doi: 10.1016/j.jhep.2017.11.029. Epub 2017 Dec 21.
Telaprevir.
[No authors listed]
Prescrire Int. 2012 Apr;21(126):93-6.
